[go: up one dir, main page]

WO2008149803A1 - Method of sorting and identifying cancer stem cells in acute lymphocytic leukemia using surface antigen markers - Google Patents

Method of sorting and identifying cancer stem cells in acute lymphocytic leukemia using surface antigen markers Download PDF

Info

Publication number
WO2008149803A1
WO2008149803A1 PCT/JP2008/060012 JP2008060012W WO2008149803A1 WO 2008149803 A1 WO2008149803 A1 WO 2008149803A1 JP 2008060012 W JP2008060012 W JP 2008060012W WO 2008149803 A1 WO2008149803 A1 WO 2008149803A1
Authority
WO
WIPO (PCT)
Prior art keywords
stem cells
lymphocytic leukemia
cancer stem
acute lymphocytic
surface antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/060012
Other languages
French (fr)
Japanese (ja)
Inventor
Chikao Morimoto
Hiroto Yamazaki
Hiroko Nishida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Original Assignee
University of Tokyo NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC filed Critical University of Tokyo NUC
Publication of WO2008149803A1 publication Critical patent/WO2008149803A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0695—Stem cells; Progenitor cells; Precursor cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

By finding surface antigen markers being positive specifically to cancer stem cells in acute lymphocytic leukemia, it is intended to provide a novel method for sorting and identifying cancer stem cells in acute lymphocytic leukemia with the use of the above markers and a kit therefor. By using surface antigen markers CD90 and CD110 as indications, cancer stem cells in T cell acute lymphocytic leukemia (T-ALL) are sorted. By using surface antigen markers CD9 or CD9 with CD90 as indications, cancer stem cells in B cell acute lymphocytic leukemia (B-ALL) are sorted.
PCT/JP2008/060012 2007-06-06 2008-05-30 Method of sorting and identifying cancer stem cells in acute lymphocytic leukemia using surface antigen markers Ceased WO2008149803A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007-150912 2007-06-06
JP2007150912 2007-06-06
JP2007159355 2007-06-15
JP2007-159355 2007-06-15

Publications (1)

Publication Number Publication Date
WO2008149803A1 true WO2008149803A1 (en) 2008-12-11

Family

ID=40093621

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/060012 Ceased WO2008149803A1 (en) 2007-06-06 2008-05-30 Method of sorting and identifying cancer stem cells in acute lymphocytic leukemia using surface antigen markers

Country Status (1)

Country Link
WO (1) WO2008149803A1 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012031280A3 (en) * 2010-09-03 2012-07-12 Stem Centrx, Inc. Identification and enrichment of cell subpopulations
JP2012522217A (en) * 2009-03-24 2012-09-20 バイオセプト インコーポレイティッド Devices and methods for cell capture and analysis
CN103547597A (en) * 2011-02-18 2014-01-29 施特姆森特Rx股份有限公司 Novel regulator and method of use
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
US9671407B2 (en) 2009-03-24 2017-06-06 Biocept, Inc. Devices and methods of cell capture and analysis
US9778264B2 (en) 2010-09-03 2017-10-03 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
US9777070B2 (en) 2014-04-30 2017-10-03 Pfizer Inc Anti-PTK7 antibody-drug conjugates
US10018630B2 (en) 2011-09-07 2018-07-10 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell isolation
US10934351B2 (en) 2011-10-28 2021-03-02 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell-specific molecule
US11124773B2 (en) 2010-10-06 2021-09-21 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell population and method for production thereof
US11536713B2 (en) 2009-12-25 2022-12-27 Chugai Seiyaku Kabushiki Kaisha Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted therein

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
FICKERT S. ET AL.: "Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers", ARTHRITIS RES. THER., vol. 6, no. 5, 2004, pages R422 - R432, XP021011511 *
INABA T. ET AL.: "Flow cytometric analysis of Thy-1 expression in myelodysplastic syndrome", INT. J. HEMATOL., vol. 68, no. 4, 1998, pages 403 - 410 *
IRIMAJIRI K.: "Hakketsubyo to Rinsho Kensa 2 Kyusei Lymph-sei Hakketsubyo (2)", MEDICAL TECHNOLOGY, vol. 16, no. 5, 1988, pages 391 - 397 *
NISHIDA H.: "B Saibo Lymph-kei Zoketsuki Shuyo ni Okeru Gan Kansaibo no Dotei to Kaiseki", RINSHO KETSUEKI, vol. 48, no. 9, 30 September 2007 (2007-09-30), pages 874 + ABSTR. NO. OS-18-5 *
RAMZI M.M. ET AL.: "Bryostatin 1 induces ubiquitin COOH-terminal hydrolase in acute lymphoblastic leukemia cells", ENZYME PROTEIN, vol. 49, 1996, pages 262 - 272, XP002916202 *
UCKUN F.M. ET AL.: "Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia", J. EXP. MED., vol. 163, no. 2, 1986, pages 347 - 368, XP000611309 *
XAVIER THOMAS ET AL.: "CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia", LEUKEMIA, vol. 9, no. 2, 1995, pages 249 - 253 *
YAMAZAKI H.: "Hito Kyusei Lymph-sei Hakketsubyo ni Okeru Gan Kansaibo no Dotei", REGENERATIVE MEDICINE, vol. 7, 22 February 2008 (2008-02-22), pages 232 + ABSTR. NO. O-32-3 *
YAMAZAKI H.: "Isolation of cancer stem cells in human T-cell acute lymphoblastic leukemia cell lines", DAI 66 KAI NIHON GAN GAKKAI GAKUJUTSU SOKAI KIJI, vol. 66TH, 25 August 2007 (2007-08-25), pages 52 *
ZHANG S.-L. ET AL.: "Analysis of surface antigen on lymphoid malignancies in children", JAPANESE JOURNAL OF PEDIATRIC HEMATOLOGY, vol. 4, no. 5, 1990, pages 457 - 462 *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9671407B2 (en) 2009-03-24 2017-06-06 Biocept, Inc. Devices and methods of cell capture and analysis
JP2012522217A (en) * 2009-03-24 2012-09-20 バイオセプト インコーポレイティッド Devices and methods for cell capture and analysis
US11719692B2 (en) 2009-03-24 2023-08-08 Biocept, Inc. Devices and methods of cell capture and analysis
US9128082B2 (en) 2009-03-24 2015-09-08 Biocept, Inc. Devices and methods of cell capture and analysis
US10527611B2 (en) 2009-03-24 2020-01-07 Biocept, Inc. Devices and methods of cell capture and analysis
US11536713B2 (en) 2009-12-25 2022-12-27 Chugai Seiyaku Kabushiki Kaisha Method for searching and screening for target of anti-cancer agent using non-human animal model having NOG established cancer cell line transplanted therein
AU2016201730B2 (en) * 2010-09-03 2018-01-25 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
US9945842B2 (en) 2010-09-03 2018-04-17 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
US9778264B2 (en) 2010-09-03 2017-10-03 Abbvie Stemcentrx Llc Identification and enrichment of cell subpopulations
WO2012031280A3 (en) * 2010-09-03 2012-07-12 Stem Centrx, Inc. Identification and enrichment of cell subpopulations
US11965180B2 (en) 2010-10-06 2024-04-23 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell population and method for production thereof
US11124773B2 (en) 2010-10-06 2021-09-21 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell population and method for production thereof
US9409995B2 (en) 2011-02-18 2016-08-09 Stemcentrx, Inc. PTK7 modulators and methods of use
US10836831B2 (en) 2011-02-18 2020-11-17 Abbvie Stemcentrx Llc Anti-PTK7 antibodies and methods of use
US9914784B2 (en) 2011-02-18 2018-03-13 Abbvie Stemcentrx Llc PTK7 modulators and methods of use
CN103547597B (en) * 2011-02-18 2017-03-15 艾伯维施特姆森特克斯有限责任公司 Novel regulator and method of use
CN103547597A (en) * 2011-02-18 2014-01-29 施特姆森特Rx股份有限公司 Novel regulator and method of use
US10018630B2 (en) 2011-09-07 2018-07-10 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell isolation
US10934351B2 (en) 2011-10-28 2021-03-02 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell-specific molecule
US11858987B2 (en) 2011-10-28 2024-01-02 Chugai Seiyaku Kabushiki Kaisha Cancer stem cell-specific molecule
US10087258B2 (en) 2012-02-08 2018-10-02 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
US9777070B2 (en) 2014-04-30 2017-10-03 Pfizer Inc Anti-PTK7 antibody-drug conjugates

Similar Documents

Publication Publication Date Title
WO2008149803A1 (en) Method of sorting and identifying cancer stem cells in acute lymphocytic leukemia using surface antigen markers
WO2007079183A3 (en) Placental stem cell populations
WO2005021728A3 (en) Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations
WO2006089091A3 (en) Methods for detecting minimum residual disease
EP4249605A3 (en) Methods for analyte detection
WO2006105152A3 (en) Amnion-derived cell compositions, methods of making and uses thereof
WO2012021795A3 (en) Pancreatic cancer biomarkers and uses thereof
WO2009048530A3 (en) Highly multiplexed particle-based assays
NO20075379L (en) A method of maintaining a well with well fluid comprising an elastic material.
WO2010033906A3 (en) Efficient induction of pluripotent stem cells using small molecule compounds
WO2008002712A3 (en) Systems and methods for integrating outsourcers
WO2007081768A3 (en) Use of he4 and other biochemical markers for assessment of ovarian cancers
WO2008118392A3 (en) Synthetic cell platforms and methods of use thereof
WO2009009240A3 (en) Automated speech recognition (asr) tiling
GB2449772A (en) Large scale production of stem cells
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
WO2006124641A3 (en) Anti-mesothelin antibodies useful for immunological assays
MX2010005891A (en) Distinguishing assay.
WO2009114185A3 (en) Methods and compositions for translational profiling and molecular phenotyping
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
DE502007004748D1 (en) TOOL HOLDER, ESPECIALLY FOR A STICK TOOL AND CUTTING BODY FOR A TOOL HOLDER
GB0600916D0 (en) detecting and predicting pre-eclampsia
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
WO2006107670A3 (en) In vitro association studies
WO2006086443A3 (en) Process and composition for froth flotation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08777023

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08777023

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP